Liberty Health Sciences to Bring Mary’s Medicinals Cannabis Products to Massachusetts Patients and Consumers

Liberty Health Sciences Signs Exclusive Agreement to Bring Award-Winning Mary’s Medicinals Cannabis Products to Massachusetts

Liberty and Mary’s expand partnership with second exclusive licensing and raw materials agreement

TORONTO, May 25, 2018 /PRNewswire/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) (“Liberty” or the “Company”) today announced the expansion of the Company’s partnership with Colorado-based MM Technology Holdings, LLC (“Mary’s”) to be the exclusive provider of the award-winning line of Mary’s Medicinals® cannabis products in Massachusetts.

Under the agreement, Liberty will produce and distribute Mary’s suite of innovative cannabis products, featuring a variety of novel delivery methods, under license in Massachusetts for both medical and recreational users, when permitted. The agreement is subject to approval by the Commonwealth of Massachusetts, Medical Use of Marijuana Program or the Massachusetts Cannabis Control Commission as is required under Massachusetts law.

We are very excited to extend our partnership with Mary’s into Massachusetts, providing consumers with access to award-winning cannabis products featuring safe and effective alternative delivery methods.

George Scorsis, Director and CEO of Liberty

Liberty has always focused on providing high-quality, clean and safe pharmaceutical grade cannabis, and partnerships with innovative brands like Mary’s ensures we’re also providing consumers with exceptional variety and choices from the best across the industry.

Best known as the developer and exclusive distributor of the award-winning Transdermal Cannabis Patch, Mary’s innovative products are forged at the intersection of technology and horticulture and are transforming how people view and utilize cannabis. Mary’s develops products and delivery methods that maximize the benefits of cannabinoids, terpenes and other plant nutrients. The agreement gives Liberty exclusive rights to produce and sell the following products in Massachusetts:

  • Mary’s Medicinals® Transdermal gels
  • Mary’s Medicinals® Transdermal/topical compounds
  • Mary’s Medicinals® Capsules
  • Mary’s Medicinals® Tinctures
  • Mary’s Medicinals® Muscle Freeze
  • Mary’s Medicinals® Vape Pens
  • Mary’s Medicinals® Distillates

Mary’s creates technologically-advanced, effective and natural pain-relief products, utilizing clinically tested, clean and accurate delivery methods. Most importantly, the company is dedicated to developing proven innovative products that have garnered numerous accolades including the 2014 Invention of the Year in the Cannabis Business Awards, Most Innovative Product at the CannAwards and Best New Product at the High Times Cannabis Cup.

We are pleased to offer our unique and creative products in the Bay State. We look forward to providing an entirely new menu of options for medical and recreational users that are clean, safe, and meticulously curated.

Lynn Honderd, CEO of Mary’s.

In October 2017, Liberty and Mary’s announced an exclusive licensing and raw materials agreement to bring Mary’s Medicinals® cannabis products to Florida.

For more information on Liberty, please visit

About Liberty Health Sciences Inc.

Liberty Health Sciences Inc. is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in U.S. states where medical cannabis is legal.  Liberty’s stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near- and mid-term opportunities.  Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer.  Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to patients.

For more information, please visit

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter